[HTML][HTML] A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa
E Saayman, V Hechter, N Kayuni… - Harm Reduction Journal, 2023 - Springer
Background Globally, 9% of people who inject drugs (PWID), a key hepatitis C-infected
population, reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in …
population, reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in …
[HTML][HTML] A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa
E Saayman, V Hechter… - Harm …, 2023 - harmreductionjournal.biomedcentral …
Globally, 9% of people who inject drugs (PWID), a key hepatitis C-infected population,
reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in PWID is high. It …
reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in PWID is high. It …
A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa
E Saayman, V Hechter, N Kayuni… - Harm Reduction …, 2023 - search.proquest.com
Background Globally, 9% of people who inject drugs (PWID), a key hepatitis C-infected
population, reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in …
population, reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in …
A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa
E Saayman, V Hechter, N Kayuni… - Harm reduction …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Globally, 9% of people who inject drugs (PWID), a key hepatitis C-infected
population, reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in …
population, reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in …
A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa.
E Saayman, V Hechter, N Kayuni… - Harm Reduction …, 2023 - europepmc.org
Background Globally, 9% of people who inject drugs (PWID), a key hepatitis C-infected
population, reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in …
population, reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in …
A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa.
E Saayman, V Hechter, N Kayuni… - Harm Reduction …, 2023 - search.ebscohost.com
Abstract Background: Globally, 9% of people who inject drugs (PWID), a key hepatitis C-
infected population, reside in sub-Saharan Africa. In South Africa, hepatitis C …
infected population, reside in sub-Saharan Africa. In South Africa, hepatitis C …
[HTML][HTML] A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa
E Saayman, V Hechter, N Kayuni… - Harm Reduction …, 2023 - ncbi.nlm.nih.gov
Background Globally, 9% of people who inject drugs (PWID), a key hepatitis C-infected
population, reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in …
population, reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in …
[PDF][PDF] A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa
E Saayman, V Hechter, N Kayuni… - 2023 - harmreductionjournal.biomedcentral …
Background Globally, 9% of people who inject drugs (PWID), a key hepatitis C-infected
population, reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in …
population, reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in …
A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa.
E Saayman, V Hechter, N Kayuni… - Harm Reduction …, 2023 - europepmc.org
Background Globally, 9% of people who inject drugs (PWID), a key hepatitis C-infected
population, reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in …
population, reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in …